Call for proffered posters

Abstract submission deadline: 30 June 2019

The Nuclear Medicine and Molecular Imaging Advisory Group (NMMAG) of the SCoR would welcome submission of posters from 
students, nuclear medicine trainees, clinical radiographers at all tiers, nuclear medicine technologists, service managers, research radiographers, educationalists, and other members of the multi-professional nuclear medicine team, within the topic areas of:

PET CT
PET MRI
Theranostics in prostate cancer, neuroendocrine tumours and thyroid cancer                                  
Commissioning of a molecular radionuclide therapy (MRT) service
Radiation protection considerations for MRT

All proffered posters must follow a set format and will be anonymously and independently assessed by the NMMAG. Those with the highest marks will be selected for presentation.

Please note that in order to display a poster, authors must register and pay to attend the conference. All accepted poster abstracts will be published in the study day booklet and there will be prizes for the best submissions.

For more information on how to present a poster, please click here. For help or advice, please contact suej@sor.org or joanneweekes@nhs.net.

Please find our proffered poster abstracts terms and conditions here.

Click here to submit your poster abstract. 

To assist you with the completion of the form, the information required has been detailed below.

Contact Information:

Author(s) Name(s)
Job roles/titles
SoR membership number, if applicable
Contact Email Address
Telephone Number

Please provide an abstract (maximum 350 words) using the headings below:

Title
Author(s)
Keywords
Introduction
Method and Materials
Results
Conclusion and Discussion
N.B. Numerical references required. Please note that references are not included in abstract word count.

Which topic area(s) best covers your work?

PET CT
PET MRI
Theranostics in prostate cancer, neuroendocrine tumours and thyroid cancer                                  
Commissioning of a molecular radionuclide therapy (MRT) service
Radiation protection considerations for MRT

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top